The ScanBalt EU Research Support Digest
Click here: Make your projects visible, reach out to stakeholders and attract business interest
Joint Programming Initiative (JPI) More Years Better Lives: Call for Proposals for “Ageing and Place in a digitising world”
This Call is concerned with the ways in which the health and wellbeing of older people, at all stages of later life, is supported and promoted through the design of the social and physical environment, access to opportunities to learn, and the use of technologies of all kinds. As it is conventional, with “older” we here broadly refer to anyone over the age of 50: from those who are still healthy and active to those in the final stages of life, whether living at home or in long-term institutions. This group is rapidly growing in the population and the experience of later life is changing for many people. Although many older people remain very active, as they age, they are increasingly likely to have particular needs in terms of their living environment. To participate in learning and to have access to new technologies -and to be able to use them- becomes even more important as we age as our conditions, prospects and abilities are changing.
Proposals Deadline 3. April 2017
More information can be found here
Joint Programming Initiative on Antimicrobial Resistance (JPI AMR): Call for transnational research projects
Comparison of prevention, control, and intervention strategies for AMR infections through multidisciplinary studies, including One Health approaches.
In order to protect and prolong the usefulness of existing antimicrobials, increasing cross-sectoral efforts are needed to rationalize their use and misuse in human and animal health and food production settings. Key measures to achieve this are to improve existing and implement new evidence-based control, prevention, stewardship and intervention strategies to reduce the risk of acquisition, development and transmission of antibiotic-resistant bacteria and infection caused by these pathogens, in hospitalized patients, outpatients, healthy people, animals and the environment. Despite significant investments in research and increased knowledge about the development, acquisition, occurrence, and transmission pathways of AMR, little of this research has translated into interventions to significantly improve health care by reducing improper antibiotic usage or infections by resistant microbes.
In summary, controlled integrated studies between human population, health care systems, and agricultural settings, multiple sectors are urgently needed to devise the optimal intervention strategies across diverse cultural settings and heterogeneous systems of human health and animal health and food production.
Pre-Proposals Deadline 21.3.2017
More information can be found here
Joint Programing Initiative: A Healthy Diet for a Healthy Life
Call on “Interrelation of the Intestinal Microbiome, Diet and Health”
It aims to support multinational, collaborative research projects that address important research questions regarding the cause-and-effect relationships between diet, the intestinal microbiome and human health. The overall aim is to build a solid knowledge base for the development of new strategies and products for health promotion and prevention of chronic diseases through diet-dependent modulation of the intestinal microbiome.
Building on the previous achievements of the joint action “Intestinal Microbiomics” this cofunded call will further enhance the collaboration between HDHL member countries, the JPI and the European Commission (EC), as well as the establishment of research networks across borders and disciplines.
The deadline of the pre-proposals is 5. April 2017
More information can be found here
ERA-NET NEURON Call for Proposals for research projects on Ethical, Legal, and Social Aspects (ELSA) of Neuroscience
The ERA-NET NEURON supports basic, clinical and translational research in the diverse fields of disease-related neuroscience. Ministries and funding organisations across Europe, Israel, Turkey and Canada have joined forces to conquer diseases of the brain and the nervous system.
The aim of the call is to facilitate multinational, collaborative research projects that will address important questions regarding ethical, philosophical, legal and socio-cultural aspects related to the neurosciences and their recent advances.
Deadline May 03, 2017
More information can be found here
Innovative Medicines Initiative 2 (IMI2); 10th call for propsals
IMI is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. The 10th call focusses one:
- Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
- How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme)
- Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain)
- Creation of a pan-European paediatric clinical trials network
- Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes
- Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs)
- Patient perspectives in medicines lifecycle
- Personalised medicine approaches in autism spectrum disorders
Stage 1 proposal deadline: 28.March 2017
More information can be found here:
HORIZON PRIZE – Low carbon hospital – € 1 million
The Horizon prize for Combined Heat and Power (CHP) installation in a hospital using 100% renewable energy sources will reward a hospital that has an innovative and perfectly integrated combined CHP installation within its premises.
The contest has been launched and you can apply until 3 April 2019.
More information can be found here:
HORIZON PRIZE – Birth Day
The Horizon Prize on reducing maternal and newborn morbidity and mortality – the Birth Day Prize – will be awarded to the contestants who demonstrate a novel solution to improve the outcome of facility-based deliveries, which might be of clinical, technological or managerial nature, or a combination of these. Any solution must take full account of relevant social factors and have the potential of scaling up rapidly.
Deadline: 06 September 2017
More information can be found here:
SME Instrument
Also in 2017, SMEs are invited to submit proposals under the SME instrument at any time within all Societal Challenges and Leadership in Enabling and Industrial Technologies areas. In the field of Life Sciences the following topics are open:
- Dedicated support to biotechnology SMEs closing the gap from lab to market
- Supporting innovative SMEs in the healthcare biotechnology sector
- Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
- Stimulating the innovation potential of SMEs for sustainable and competitive agriculture, forestry, agri-food and bio-based sectors
- Supporting SMEs efforts for the development – deployment and market replication of innovative solutions for blue growth
Depending on which phase you are interested to apply for, the following cut-off days exist:
| Phase1: | Next cut-off-dates: 03.05.2017, 06.09.2017, 08.11.2017 |
| Phase2: | Next cut-off-dates: 06.04.2017, 01.07.2017, 18.10.2017 |
More information can be found here:
Future and Emerging Technologies (FET) Open: Research and innovation actions
FETOPEN-01-2016-2017
The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas. Here agile, risk-friendly and highly interdisciplinary research approaches are needed with collaborations that are open to all sciences and disciplines and that dissolve the traditional boundaries between them. The renewal of ideas is complemented by the renewal of actors taking these new ideas forward. Therefore, this topic encourages the driving role of new high-potential actors in research and innovation, such as excellent young, both female and male, researchers and high-tech SMEs that may become the scientific and industrial leaders of the future.
More information can be found here:
Next cut-off date: 27 September 2017
Pre-Announcement PPP- Bio-Based Industries (BBI)
This Joint Undertaking is a Public-Private Partnership between the EU and the Bio-based Industries Consortium. Operating under Horizon 2020, it is driven by the Vision and Strategic Innovation and Research Agenda (SIRA) developed by the industry.
The Annual Work Plan (AWP) 2017 contains the 2017 topic texts.
More information (guide for applicants, FAQ list, etc) will be published once the 2017 Call for proposals officially opens.
The tentative timing of the Call for Proposals 2017 is as follows:
- Call opens: April
- Call closes: September
- Evaluations: September-November
- Results published: December
More information can be found here
